High concentrations of VEGF reduce stretch-induced apoptosis of alveolar type II cells Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Regulation of human adult primary alveolar type II cell surfactant protein production by epithelial growth factors and pro-inflammatory cytokines Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009
Modulation of surfactant metabolism in type II cells from injured lungs by TNF-α and IL-10 Source: Eur Respir J 2003; 22: Suppl. 45, 78s Year: 2003
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
IL-18, a novel Th1 cytokine, is up-regulated in pulmonary tuberculosis: expression and production by alveolar epithelial cells type II Source: Eur Respir J 2002; 20: Suppl. 38, 213s Year: 2002
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011
Protein S inhibits the secretion of inflammatory cytokines from alveolar epithelial cells Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Increased TGF-β-inducible early gene (TIEG) in human eosinophils stimulated by Th-2 type inflammatory cytokines Source: Eur Respir J 2005; 26: Suppl. 49, 659s Year: 2005
Alveolar type II cells harbouring SARS-CoV-2 show senescence with a proinflammatory phenotype Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021
Cytokine production of alveolar macrophages is decreased by OR2AT4 Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Production of collagen I mRNA by bronchial epithelial cell lines and absence of modulation by Th2 cytokines Source: Eur Respir J 2004; 24: Suppl. 48, 98s Year: 2004
Moxifloxacine increases the tolerance of alveolar type II cells to mechanical stretch Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008
Histamine-stimulated monocytes release microparticles that upregulate IL-8 synthesis by human alveolar epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 228s Year: 2006
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
Modulation of NOS2 expression in co-cultures of human alveolar epithelial cells type II and alveolar macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001
Protease activated receptor 2 (PAR2) antagonism reduces pro-inflammatory cytokine production in bronchial epithelial cells Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020
Statins suppress LPS-induced proinflammatory cytokine production from human bronchial epithelial cells Source: Annual Congress 2009 - Epithelial cell biology Year: 2009
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002
Effects of mechanical intermittent positive pressure strain on cytokine formation of alveolar macrophages in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 417s Year: 2002
Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007